Industry

CMS updates guidance on prior authorization transparency

Healio Optometry5d ago1 min read

CMS has updated its guidance on prior authorization metrics reporting, addressing the AMA’s concerns about how health insurers were disclosing requirements and outcomes, according to the organization.The AMA said it notified CMS about issues with reporting metrics after it conducted a review examining how 15 Medicare Advantage contracts were abiding by the transparency requirements from CMS’s 2024 Interoperability and Prior Authorization final rule.The review showed that “on the surface, many plans appeared to comply with the rule while presenting disclosures in places and formats that made

Read full article on Healio Optometry

AI Summary

Quick Take

CMS has issued updated guidance to improve the transparency of prior authorization metrics after the AMA flagged that Medicare Advantage plans were obscuring data. The move aims to ensure that insurers' disclosures regarding prior authorization (PA) requirements and outcomes are genuinely accessible rather than hidden in obscure formats.

Why It Matters

Prior authorization remains a primary administrative hurdle in eye care, often delaying time-sensitive treatments for retina and glaucoma patients. By tightening transparency requirements, CMS is making it harder for Medicare Advantage plans to hide restrictive approval patterns. This data is essential for practices to understand which payers are most likely to delay care and for advocacy groups to push for broader PA reform based on hard evidence of denial rates.

Key Details

The guidance update follows an AMA review of 15 Medicare Advantage contracts regarding their compliance with the CMS 2024 Interoperability and Prior Authorization final rule.
The AMA's review revealed that many plans appeared to comply with transparency rules on the surface while using formats and locations that made the data difficult to find.
The updated guidance specifically addresses how health insurers must disclose PA requirements and outcomes to ensure they meet the intent of the transparency mandate.
The focus of the reporting metrics includes how often PA is required and the specific outcomes of those requests.

Practice Implications

Practice managers and clinicians should look for these newly transparent metrics to evaluate the administrative burden associated with specific Medicare Advantage plans. This data can help practices better anticipate approval timelines and provide patients with more accurate expectations regarding treatment delays caused by specific insurers.

Who's Affected

Practice OwnersOphthalmologistsOptometristsBilling and Coding StaffRetina Specialists

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.